MemoGut effect on IBS

Evaluating the efficacy of Boswellia carterii, Zingiber officinale and Achillea millefolium on severity of symptoms of irritable bowel syndrome

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201402089256N3

Enrollment

Registered

2014-05-14

Start date

2014-02-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable bowel syndrome. Irritable bowel syndrome

Interventions

Intervention 1: in case group patients use Memogut capsule three times per day for a month. Intervention 2: in control group patients use starch as placebo 3 times a day for one month.

Treatment - Drugs

Placebo

in case group patients use Memogut capsule three times per day for a month.

in control group patients use starch as placebo 3 times a day for one month

Eligibility

Sex/Gender

All

Age

18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with IBS; age older than 18 years old. Exclusion criteria: using other medications; pregnancy; incomplete medication; participants tend to exit from study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Severity of symptoms. Timepoint: Baseline, 1 and 3 months after baseline. Method of measurement: Farsi and valid IBS-SSS questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Toghiani

Isfahan University of Medical Sciences

Alitoghiani@gmail.com+98 31 1450 1568

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026